Independently verified · Janoshik + Testides

Lab Results

Every batch is independently third-party tested before it ships — and published here in full. No login, no exceptions.

Two independent labs — Janoshik + Testides

Every batch is verified twice. First it's assayed by Janoshik Analytical, a widely-recognised independent testing lab, before release. Then we send the same batch to Testides in Toronto for our own confirmatory HPLC and mass-spec testing — each certificate below links straight to the lab's portal, no login required. Batches still at Testides show their Janoshik result in the meantime.

Every batch, published

We don’t ask you to take a purity number on faith. Every batch is sent to an independent third-party lab and the full certificate is published here — single-peptide lots and pre-blended vials alike, at their actual measured HPLC purity. Any lot still at the lab carries a pending badge until its certificate is released, so you always see exactly where each batch stands.

Published results — July 2026 batch

4 of 12 samples are back from Testides. The three single-peptide lots each returned ≥99.6% HPLC purity; the BPC-157 + TB-500 blend returned 98.64% combined. The remaining eight are still in testing.

VERIFIED BATCH

Certificate of Analysis · Testides

99.65%

HPLC-UV purity

Tirzepatide 10mg

LotTIRZ10-0626-01
Content10.34 mg
MethodHPLC-UV 214nm
ReportedJul 2, 2026
View COA on Testides →
VERIFIED BATCH

Certificate of Analysis · Testides

99.68%

HPLC-UV purity

Retatrutide 10mg

LotRETA-0626-01
Content11.88 mg
MethodHPLC-UV 214nm
ReportedJul 2, 2026
View COA on Testides →
VERIFIED BATCH

Certificate of Analysis · Testides

99.64%

HPLC-UV purity

BPC-157 10mg

LotBPC10-0626-01
Content10.99 mg
MethodHPLC-UV 214nm
ReportedJul 2, 2026
View COA on Testides →
VERIFIED BATCH

Certificate of Analysis · Testides

98.64%

HPLC-UV purity (combined)

Wolverine Blend 10mg
(BPC-157 + TB-500)

LotHEAL-0626-01
Content10.78 mg
MethodHPLC-UV 214nm
ReportedJul 7, 2026
View COA on Testides →

Retatrutide 20mg and 30mg — blind-tested at Janoshik

Both lots were independently assayed by Janoshik Analytical on a blind GLP-1 panel. They're now with Testides in Toronto for our own confirmatory HPLC, as with the lots further down this page.

What a blind test is, and why it is stronger proof than a standard assay

Both lots below were submitted to Janoshik as a common GLP-1 peptide blind test. The lab was given three candidate compounds — semaglutide, tirzepatide and retatrutide — and was not told which of the three the sample was. In both cases Janoshik identified the material as retatrutide from its own analysis.

That distinction matters. A standard assay starts from the label: the lab is told what the sample is supposed to be and reports whether it found it. A blind test cannot confirm a label it was never shown, so it rules out the most common weakness in a peptide certificate — a lab result that only echoes what the vial already claims. Here, identity was established independently of the labelling.

Each lot's Janoshik reference number is printed on its card below — #207689 for the 20 mg lot and #210575 for the 30 mg lot — alongside the assayed purity and net content.

MANUFACTURER TESTED · PENDING

Independent assay · Janoshik

99.643%

HPLC purity

Retatrutide 20mg

Content24.51 mg
MethodHPLC · Janoshik
Janoshik ref#207689
AssayedJul 2026
Janoshik result — pending confirmation at Testides. Our own certificate publishes here once released.
MANUFACTURER TESTED · PENDING

Independent assay · Janoshik

99.751%

HPLC purity

Retatrutide 30mg

Content34.20 mg
MethodHPLC · Janoshik
Janoshik ref#210575
AssayedAug 2026
Janoshik result — pending confirmation at Testides. Our own certificate publishes here once released.

Net content on both lots assayed above label weight — 24.51 mg against a 20 mg label and 34.20 mg against a 30 mg label, consistent with the 11.88 mg recorded for the Testides-verified 10 mg lot above. Net content is the assayed mass of peptide in the vial as reported by the laboratory.

Still in testing — manufacturer results

These lots are already independently assayed by Janoshik Analytical, the manufacturer's third-party lab. They're now with Testides in Toronto for our own confirmatory HPLC — each card below is replaced by a full Testides certificate the moment it is released.

MANUFACTURER TESTED · PENDING

Independent assay · Janoshik

99.664%

HPLC purity

Semaglutide 10mg

Content11.42 mg
MethodHPLC · Janoshik
Janoshik ref#171488
AssayedJun 2026
Janoshik result — pending confirmation at Testides. Our own certificate publishes here once released.
MANUFACTURER TESTED · PENDING

Independent assay · Janoshik

99.247%

HPLC purity

Semaglutide 5mg

Content6.05 mg
MethodHPLC · Janoshik
Janoshik ref#101805
AssayedJan 2026
Janoshik result — pending confirmation at Testides. Our own certificate publishes here once released.
MANUFACTURER TESTED · PENDING

Independent assay · Janoshik

99.025%

HPLC purity

MOTS-C 10mg

Content11.82 mg
MethodHPLC · Janoshik
Janoshik ref#147077
AssayedApr 2026
Janoshik result — pending confirmation at Testides. Our own certificate publishes here once released.
MANUFACTURER TESTED · PENDING

Independent assay · Janoshik

99.490%

HPLC purity

GHK-Cu 50mg

GHK content50.43 mg
MethodHPLC · Janoshik
Janoshik ref#210586
AssayedAug 2026
Janoshik result — pending confirmation at Testides. Our own certificate publishes here once released.
MANUFACTURER TESTED · PENDING

Independent assay · Janoshik

99.673%

HPLC purity

Ipamorelin 10mg

Content10.68 mg
MethodHPLC · Janoshik
Janoshik ref#169441
AssayedJun 2026
Janoshik result — pending confirmation at Testides. Our own certificate publishes here once released.
MANUFACTURER TESTED · PENDING

Independent assay · Janoshik

Identity +
content ✓

Blend — purity not assayed on blends

CJC-1295 + Ipamorelin 10mg

Ipamorelin5.96 mg
CJC-1295 (mod GRF 1-29)5.07 mg
MethodID + amount · Janoshik
Janoshik ref#209639 · Jul 2026
Janoshik result — pending confirmation at Testides. Our own certificate publishes here once released.

What we test for

Every batch is screened on three independent measures before it's cleared to ship.

Identity

LC-MS/MS

Confirms the compound in the vial actually matches what's on the label.

Purity

HPLC-UV

Measures the exact purity percentage of the peptide — the headline number on every COA.

Endotoxin

LAL method

Screens for bacterial endotoxins, a key marker of contamination.

Questions about our testing?

If you have a question about a specific batch result, need documentation for your research institution, or want to verify a sample ID, email us at info@thepeptide.ca.

All products sold by ThePeptide.ca are intended strictly for laboratory and in-vitro research purposes only. Not for human or veterinary use.